Tirzepatide vs Semaglutide: Which Weight Loss Drug Works Best

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and tirzepatide dominate the weight loss medication landscape, but they work through different biological mechanisms. Clinical trials show tirzepatide produces greater average weight loss—up to 22% of body weight—compared to semaglutide's 15% average, though individual results vary significantly based on genetics and metabolism.

What Is Tirzepatide and How Does It Differ From Semaglutide?

Tirzepatide belongs to a newer class called GLP-1 receptor agonists with added GIP receptor activation—a dual-hormone approach. Semaglutide targets only the GLP-1 receptor, which signals fullness and slows stomach emptying. This fundamental difference means tirzepatide engages two separate appetite-control pathways in your brain and body, potentially explaining why some patients respond better to one drug over the other.

Both medications work on the same general principle: reducing hunger signals and improving blood sugar control. The key distinction is that tirzepatide's dual mechanism may amplify weight loss results in certain individuals, particularly those with specific genetic variations affecting GIP and GLP-1 receptor sensitivity. Your genetic makeup—not just trial averages—determines which compound aligns with your metabolic profile.

Clinical Evidence: Weight Loss Comparison Between the Two Drugs

Landmark clinical trials reveal measurable differences in efficacy. The SURMOUNT trials for tirzepatide showed average weight reductions of 20–22% at the highest dose, while semaglutide's STEP trials documented 15–18% average loss. However, these population-wide averages mask individual variation: some patients lose more on semaglutide, others on tirzepatide, depending on how their body responds to GIP versus GLP-1 pathway activation.

Response rates also differ by baseline metabolic factors. Patients with insulin resistance may benefit more from tirzepatide's dual-hormone effect, while those with primary satiety dysfunction might achieve better results with semaglutide's focused GLP-1 action. PlexusDx's Precision Peptide Genetic Test maps 14 distinct pathways across 49 peptides, revealing which genetic variants in your GLP1R, GIPR, and other weight-regulation genes predict stronger response to each compound.

Understanding the GLP-1 Receptor Agonist Family and Newer Options

The GLP-1 receptor agonist class includes semaglutide (Ozempic, Wegovy), tirzepatide (Zepbound, Mounjaro), and other compounds. Tirzepatide's addition of GIP receptor activity marks it as a 'GLP-1/GIP receptor agonist,' a distinct subcategory that recent research suggests may offer cumulative metabolic advantages. Both drug families reduce appetite, improve insulin secretion, and slow gastric emptying—but via slightly different downstream mechanisms in your cells.

PlexusDx offers both semaglutide and tirzepatide formulations—injections and oral versions—to match your preference and response profile. The company also provides GLP-Squared, a dual-compound injectable combining semaglutide and tirzepatide, designed for patients who benefit from simultaneous activation of both GLP-1 and GIP pathways. Starting at $249 per month for GLP-Squared injection, this option represents a personalized third pathway when single agents plateau.

How Genetics Predict Your Optimal Weight Loss Medication

Your DNA contains variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO (rs9939609), and MC4R (rs17782313) that influence how strongly you respond to each drug. A patient carrying certain GIPR variants may experience superior appetite suppression with tirzepatide, while another with specific GLP1R variants achieves better results on semaglutide. One-size-fits-all prescribing ignores this molecular reality and often leads to suboptimal outcomes.

PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month of treatment) analyzes 14 metabolic and appetite pathways spanning 150+ genetic insights. This test reveals your peptide-pathway predispositions—not just pharmacogenomic data—enabling your clinician to select semaglutide injection (from $149/mo), tirzepatide injection (from $249/mo), oral versions, or dual-compound formulations with confidence that the choice aligns with your unique biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is tirzepatide more effective than semaglutide for weight loss?

Tirzepatide shows higher average weight loss in clinical trials (20–22%) compared to semaglutide (15–18%), but individual response varies widely based on genetics and metabolism. Some patients lose more on semaglutide; others excel on tirzepatide.

Why does tirzepatide activate GIP in addition to GLP-1?

GIP and GLP-1 are two separate appetite-control hormones that work through distinct brain regions and metabolic pathways. Activating both via tirzepatide can produce synergistic fullness and glucose-control effects in patients whose genetics favor dual-hormone activation.

What is the price difference between semaglutide and tirzepatide at PlexusDx?

PlexusDx compounded semaglutide injection starts at $149/month, while compounded tirzepatide injection starts at $249/month. Your dose may need to go up during treatment, but your monthly price won't increase. Both are available from licensed 503A compounding pharmacies and work with HSA/FSA accounts; no insurance or membership fee required.

Are compounded semaglutide and tirzepatide as safe as brand-name versions?

PlexusDx sources all medications from licensed 503A compounding pharmacies, which follow strict quality and sterility standards regulated by state pharmacy boards. While compounded medications are not FDA-approved (brand-name versions are), the compounding process itself is legally overseen.

How does the Precision Peptide Genetic Test help me choose between these drugs?

The test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 other metabolic pathway genes, revealing which appetite-regulation mechanisms are most active in your body. If your genetics show strong GIP sensitivity, tirzepatide may outperform semaglutide. If GLP-1 dominates your profile, semaglutide injection at $149/mo may be ideal.

What is the Other Weight Loss Drug Besides Semaglutide?